ECXK.F (ECXK.F) News
Follow ECXK.F (ECXK.F) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Epigenomics adjusts conversion price on outstanding mandatory convertible bond after EUR 219,244 capital increase
Epigenomics reset the conversion price on its mandatory convertible bond 2021/2027 following a registered cash capital increase. Adjusted conversion ratio set at 1 (nominal EUR 100): 4.7438 shares, effective Oct. 15, 202
EQUITY | Oct 14, 2026, 11:35 AM UTC
L
Epigenomics reports total voting rights at 1,096,220
Epigenomics disclosed 1,096,220 total voting rights as of Oct. 14, 2026. No multiple voting rights were outstanding. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intel
NEWS | Oct 14, 2026, 09:45 AM UTC